Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
De Morsier's Syndrome, also known as septo-optic dysplasia (SOD), is a rare congenital (present at birth) brain abnormality. It is characterized by three main features: underdevelopment of the optic nerve, absence of the septum pellucidum (a membrane in the brain), and pituitary gland dysfunction.
read more about de morsiers syndrome ...The primary cause involves developmental defects during early foetal gestation, often linked to mutations in certain genes. The condition is defined by the absence or underdevelopment of the septum pellucidum, a thin membrane separating the frontal ventricles of the brain, and the structural abnormalities of the optic nerve and chiasm.
This absence of tissue affects brain structure, and the failure of the midline development causes hormonal and visual problems. The structural abnormality of the brain is present from birth, although the severity of hormonal issues can become apparent later in childhood.
Symptoms associated with pituitary dysfunction are systemic and varied. The pituitary gland may fail to produce adequate growth hormone, thyroid hormone, and cortisol, leading to growth delays, metabolic problems, and unstable blood sugar levels. The hormonal deficiencies require lifelong replacement therapy. Infants may present with severe hypoglycemia (low blood sugar), which is a life-threatening symptom requiring immediate intervention.
De Morsier's Syndrome severely impacts vision due to optic nerve hypoplasia (underdevelopment of the optic nerve). This underdevelopment means the nerve fibers are permanently reduced in number, resulting in varying degrees of vision loss or blindness that cannot be corrected with glasses. Other ocular issues include nystagmus (uncontrolled eye movements) and strabismus (eye misalignment).
Diagnosis is often suspected in infancy. Magnetic Resonance Imaging (MRI) is used to confirm the brain abnormalities (absence of the septum pellucidum and small optic nerves). Blood tests confirm pituitary hormone deficiencies. Early diagnosis is critical for beginning hormone replacement therapy.
Necessary management strategies are multidisciplinary. Treatment involves lifelong hormone replacement therapy (cortisol, growth hormone, etc.), specialized education for visual impairments, and management of neurological issues like seizures.
No, the structural brain and optic nerve abnormalities are permanent, but hormonal deficiencies are treatable.
No, the severity is highly variable. Some individuals have mild vision loss, while others are profoundly affected.
It is a thin membrane in the brain that is partially or completely absent in patients with this syndrome.
Children with Septo-Optic Dysplasia (De Morsier's) require a team of specialists, including an endocrinologist and a pediatric ophthalmologist. Watch for signs of hormone failure, such as poor growth or low blood sugar. Early visual stimulation therapy can help maximize any residual sight.
NORD. Septo-Optic Dysplasia (rarediseases.org). 2024.
Mayo Clinic. Septo-Optic Dysplasia (mayoclinic.org). 2024.
Cleveland Clinic. Septo-Optic Dysplasia (clevelandclinic.org). 2024.
StatPearls. Septo-Optic Dysplasia (ncbi.nlm.nih.gov). 2024.